Literature DB >> 8957357

Cancer resection on the residual lung after pneumonectomy for bronchogenic carcinoma.

L Spaggiari1, D Grunenwald, P Girard, P Baldeyrou, M Filaire, G Dennewald, O Saint-Maurice, L Tric.   

Abstract

BACKGROUND: After pneumonectomy for bronchogenic carcinoma, the residual lung may be the site of a new lung cancer or metastatic spread.
METHODS: From 1989 to 1995, 13 patients with carcinoma on the residual lung after pneumonectomy for lung cancer were operated on. Three segmentectomies and 7 simple wedge resections were performed, 2 patients had multiple wedge resections, and 1 patient had an exploratory thoracotomy. Nine patients had a primary metachronous bronchogenic carcinoma, 3 had metastases from bronchogenic carcinoma, and no definite conclusion was reached in 1 case.
RESULTS: No postoperative mortality was observed. Four patients had postoperative complications. The mean postoperative hospital stay was 14 days. Seven patients are alive, including 5 patients without evidence of disease. Six patients died of their disease, all with pulmonary recurrences. The overall median survival was 19 months, with a probability of survival at 3 years (Kaplan-Meier) of 46% (95% confidence interval, 22% to 73%).
CONCLUSIONS: Limited pulmonary resection for lung cancer after pneumonectomy for bronchogenic carcinoma is feasible with very low morbidity. In highly selected patients, surgical resection might prolong survival.

Entities:  

Mesh:

Year:  1996        PMID: 8957357     DOI: 10.1016/s0003-4975(96)00608-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Pneumothorax after pneumonectomy: surgery with successful double lobe ventilation.

Authors:  Tomohiro Maniwa; Yukihito Saito; Hiroyuki Kaneda; Hiroji Imamura; Kouhei Murao; Koh Shingu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-08

2.  Video-assisted thoracoscopic management for emphysema associated with contralateral destroyed lung.

Authors:  Xin Xu; Hanzhang Chen; Weiqiang Yin; Bing Wei; Dong Xiao; Jun Liu; Jianxing He
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

3.  Stereotactic body radiation therapy for a new lung cancer arising after pneumonectomy: dosimetric evaluation and pulmonary toxicity.

Authors:  Alessandro Testolin; Maria Silvia Favretto; Stefania Cora; Carlo Cavedon
Journal:  Br J Radiol       Date:  2015-08-20       Impact factor: 3.039

4.  Pulmonary radiofrequency ablation in a single lung patient.

Authors:  M C Ambrogi; O Fanucchi; R Lencioni; R Cioni; A Mussi
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

5.  Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy.

Authors:  Christoph Pöttgen; Jehad Abu Jawad; Eleni Gkika; Lutz Freitag; Wolfgang Lübcke; Stefan Welter; Thomas Gauler; Martin Schuler; Wilfried Ernst Erich Eberhardt; Georgios Stamatis; Martin Stuschke
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

6.  Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes.

Authors:  Sashendra Senthi; Cornelis J A Haasbeek; Frank J Lagerwaard; Wilko F Verbakel; Patricia F de Haan; Ben J Slotman; Suresh Senan
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

7.  Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery.

Authors:  Congkuan Song; Zilong Lu; Donghang Li; Shize Pan; Ning Li; Qing Geng
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

8.  Right lower lobectomy eight years after left pneumonectomy for a second primary lung cancer.

Authors:  Yunpeng Liu; Peipeng Cui; Zhiguang Yang; Peng Zhang; Rui Guo; Guoguang Shao
Journal:  J Cardiothorac Surg       Date:  2013-03-15       Impact factor: 1.637

9.  Computed tomography-guided percutaneous microwave ablation of early stage non-small cell lung cancer in a pneumonectomy patient.

Authors:  Zhigang Wei; Jiao Wang; Xin Ye; Xia Yang; Guanghui Huang
Journal:  Thorac Cancer       Date:  2015-06-15       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.